← Evidence map

ArticleOncogene2024

IFI35 limits antitumor immunity in triple-negative breast cancer via CCL2 secretion.

Baojin Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38216673